One governance detail that fits your read on the new team: on Oct 9 both Steven Rales (Chairman) and Mitchell Rales (Chair of the Executive Committee) waived the 500,000-share RSU awards they were each granted on Aug 4, for no consideration, per their Form 4s filed Oct 14.
Corporate BS has come to epitomise Danaher unfortunately.
Culturally, this is not the same company it was a decade ago, in my opinion. It's become highly bureaucratic with strategy valued much more than operational execution.
Reporting core growth ex-respiratory at 5.5% while respiratory was still a roughly 250 bps headwind makes the headline 3% organic number look weaker than the underlying trend. Also worth noting that about 650 bps of the 8.5% revenue growth came from Masimo, so the organic picture is much closer to the 3% core figure.
One governance detail that fits your read on the new team: on Oct 9 both Steven Rales (Chairman) and Mitchell Rales (Chair of the Executive Committee) waived the 500,000-share RSU awards they were each granted on Aug 4, for no consideration, per their Form 4s filed Oct 14.
Corporate BS has come to epitomise Danaher unfortunately.
Culturally, this is not the same company it was a decade ago, in my opinion. It's become highly bureaucratic with strategy valued much more than operational execution.
Reporting core growth ex-respiratory at 5.5% while respiratory was still a roughly 250 bps headwind makes the headline 3% organic number look weaker than the underlying trend. Also worth noting that about 650 bps of the 8.5% revenue growth came from Masimo, so the organic picture is much closer to the 3% core figure.